| Company | Reagent | Link to information | Remarks |
| Abcam | Human PF4 ELISA Kit |
Method: ELISA Assay principle: one step Entity: Quantitative Antibodies: Monoclonal |
|
| Aesku Diagnostics | Aeskulisa HIT II |
Method: EIA Assay principle: two step Entity: Qualitative and quantitative |
|
| Aesku Diagnostics | Aeskulisa HIT II Check |
Method: EIA Assay principle: Two step Entity: Qualitative and quantitative |
|
| Akers Biosciences | PIFA Heparin/PF4 | Method: PIFA
Entity: Qualitative |
|
| BIO-RAD | ID-PaGIA Heparin/PF4 Antibody Test | Method: PAGIA
Entity: Qualitative |
|
| Creative Diagnostics | Heparin-PF4complex/ HIT IgM |
Method: ELISA Assay principle: Two step Entity: Qualitative |
|
| Hyphen BioMed | Zymutest HIA IgG | Hyphen Zymutest HIA IgG |
Method: ELISA Assay principle: Two step Entity: Qualitative Antibodies: Polyclonal |
| Hyphen BioMed | Zymutest HIA IgGAM | Hyphen Zymutest HIA IgGAM |
Method: ELISA Assay principle: Two step Entity: Qualitative Antibodies: Polyclonal |
| Hyphen BioMed | Zymutest HIA IgM | Hyphen Zymutest HIA IgM |
Method: ELISA Assay principle: Two step Entity: Qualitative Antibodies: Polyclonal |
| IBL International | HIT II-Ab ELISA |
Method: ELISA Assay principle: Two step Entity: Qualitative Antibodies: Polyclonal |
|
| IMMUCOR | LIFECODES PF4 Enhanced |
Method: ELISA Assay principle: Two step Entity: Qualitative Antibodies: Polyclonal |
|
| IMMUCOR | LIFECODES PF4 IgG |
Method: ELISA Assay principle: Two step Entity: Qualitative Antibodies: Polyclonal |
|
| IQ Products | HIT Alert |
Method: Lateral Flow Immunoassay Entity: Qualitative Antibodies: Monoclonal |
|
| Milenia Biotec | MQ HIT |
Method: Lateral Flow Immunoassay Entity: Qualitative Antibodies: Polyclonal |
|
| MyBioSource | Heparin associated antibody (HIT) |
Method: ELISA Assay principle: Two step Entity: Qualitative |
|
| Stago | Asserachrom HPIA | Stago Asserachrom HPIA |
Method: ELISA Assay principle: Two step Entity: Qualitative Antibodies: Polyclonal |
| Stago | Asserachrom HPIA-IgG | Stago Asserachrom HPIA-IgG |
Method: ELISA Assay principle: Two step Entity: Qualitative Antibodies: Polyclonal |
| Stago | Stic Expert HIT | Stago Stic Expert HIT | Method: Lateral Flow Immunoassay
Entity: Qualitative Antibodies: Polyclonal |
| Werfen | HIT-Ab | Werfen HemosIL HIT-Ab |
Method: LIA Assay principle: Immunoturbidimetric method Antibodies: Monoclonal |
| Werfen | Acustar HIT IgG | Werfen AcuStar HemosIL HIT IgG |
Method: Chemiluminescent immunoassay Assay principle: Two step Antibodies: Monoclonal |
- Special Information
- Calendar
- Assays
- Fibrinogen
- APTT
- Factor IX chromogenic methods
- PT/INR
- Antithrombin activity
- Antithrombin antigen
- Protein C activity
- Protein C antigen
- Protein S activity
- Protein S antigen (Free)
- Protein S antigen (Total)
- Activated protein C resistance ratio
- Protein C pathway test
- Lupus anticoagulant
- Antiphospholipid antibodies (Anticardiolipin)
- Antiphospholipid antibodies (α2-Glycoprotein I)
- D-Dimer
- Activator VIII IX XI XII
- Deficient plasma VIII IX XI XII
- Factor IX antigen
- Calibrators VIII IX XI XII
- Factor VIII antigen
- Factor VIII chromogenic methods
- Activator II V VII X
- Prothrombin (factor II) chromogenic methods
- Deficient plasma II V VII X
- Calibrators II V VII X
- VWF antigen
- VWF collagen binding assay
- VWF multimers
- VWF Activity
- VWF:RiCoF
- Factor XIII activity
- Factor XIII antigen
- Factor VIII deficient plasma
- Normal pooled plasma
- Immunological test
- Plasminogen activity
- Plasminogen antigen
- Plasmin inhibitor activity
- PAI-1 antigen
- PAI-1 activity
- t-PA antigen
- t-PA activity
- Method homocysteine
- ECAT Newsletter
- Terminology
- Links